-
Youd think it would be easy to recruit patients for studies just put an ad in the paper or talk to patients at the clinic. Everyone wants to help science advance, right? Maybe, but that doesnt mean they want to be a subject in a clinical trial.
-
Removing financial incentives to providers and employers that are designed to influence coverage decisions and recruiting patient representatives to participate in designing health care benefit packages are two measures that can help ensure that health care coverage decisions are fair and equitable, says a new report from an independent research arm of the American Medical Association (AMA) in Chicago.
-
A new study from researchers at the Dana-Farber Cancer Institute in Boston indicates that a long-held belief among oncologists that patients who participate in clinical trials have better outcomes overall than those who do not may not be supported by empirical evidence.
-
-
As the number of international research protocols increase, the problems faced by reviewing IRBs increase. International research is taking more and more IRB time, says Howard Guenther, PhD, MBA, associate vice chancellor for research and interim executive secretary of the Institutional Review Board at the University of Illinois at Urbana-Champaign.
-
Your next patient is a 17-year-old female who is interested in contraception. While she says she knows about the contraceptive patch and the vaginal ring, when you ask her about their effectiveness in preventing sexually transmitted diseases (STDs), she gives you a puzzled look.
-
Two potential candidates in the microbicide research pipeline are set to be examined in clinical trials this fall, with research to focus on the safety and acceptability in healthy women and women infected with HIV.
-
The emergency contraceptive (EC) Plan B may be available over the counter (OTC) to women ages 16 and older if the Food and Drug Administration (FDA) approves Pomona, NY-based Barr Pharmaceuticals revised request for OTC status.
-
-
Pulmonary embolism (PE) is an illness that frequently presents with nonspecific symptoms, that affects people of all ages and stages of life, and that is difficult to diagnose with available tests. The first article in this two-part series will cover the epidemiology of PE, the factors that increase a patients risk for the disease, and the pathophysiology and clinical features of PE. In addition, complicated issues regarding the diagnosis of PE and the controversies involved will be addressed.
